Product Name |
Recombinant Human LIFR Protein |
Product Overview |
This recombinant human LIFR protein includes amino acids 45-833aa of the target gene is expressed in Baculovirus-Insect Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id |
P42702 |
Recommended Name |
Leukemia inhibitory factor receptor |
Gene Name |
LIFR |
Synonyms |
Leukemia inhibitory factor receptor, LIFR, CD118, LIF-R, SJS2, STWS, SWS |
Species |
Human |
Predicted Molecular Mass |
90.5 kDa |
Expression System |
Insect Cell |
Expression Range |
45-833aa |
Tag |
N-6His |
Purity |
>85% |
Formulation |
Lyophilized |
Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
Target Function |
Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells. |
Subcellular Location |
[Isoform 1]: Cell membrane; Single-pass type I membrane protein.; [Isoform 2]: Secreted. |
Protein Family |
Type I cytokine receptor family, Type 2 subfamily |
Associated Diseases |
Stueve-Wiedemann syndrome (STWS) |